JAZZ vs ROLR · P/E 1988, rev $2.28B vs rev $20.5M
Jazz Pharmaceuticals PLC (JAZZ) versus High Roller Technologies, Inc. (ROLR) — a side-by-side from cached financials, not a winner call.
Jazz Pharmaceuticals PLC (JAZZ) is a biotechnology company listed on US.
High Roller Technologies, Inc. (ROLR) is a gambling company listed on US.
Latest reported JAZZ revenue for 2026-06-30 was $2.28B. Net income was $485.9M. JAZZ currently screens at market cap $14.97B and trailing P/E 1988.1.
Latest reported ROLR revenue for 2025-12-31 was $20.5M. Net income was $3.2M. Revenue was down 26.6% from 2024-12-31 to 2025-12-31. ROLR currently screens at market cap $21.9M.
JAZZ currently screens at market cap $14.97B and trailing P/E 1988.1. ROLR currently screens at market cap $21.9M.
Not investment advice. Open the JAZZ and ROLR stock pages for the full models.
Not investment advice.